Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Combination Therapy
50%
Adjuvant Therapy
50%
Treatment Resistant Depression
50%
Effect Size
50%
Bipolar Disorder
50%
Neurodegenerative Disorder
50%
Observational Study
50%
Mental Disorder
50%
Speech Test
33%
Major Depressive Episode
25%
Ketamine
16%
Aripiprazole
16%
Risperidone
16%
Recurrent Disease
8%
Cognitive Behavioral Therapy
8%
Placebo Effect
8%
Therapy Effect
8%
Placebo
8%
Randomized Controlled Trial
8%
Prevalence
8%
Depressive Disorder
8%
Mirtazapine
8%
Antidepressant
8%
Formant
8%
Olanzapine
8%
Quetiapine
8%
Mood Disorder
8%
Executive Function
8%
Short Term Memory
8%
Diseases
8%
Degenerative Disease
8%
Early Intervention
8%
Computer Science
Executive Control
50%
Voice Quality
50%
Registration Number
50%
binary classifier
50%
Open Access Publication
50%
Smartphone App
50%
Acoustic Feature
50%
Specific Symptom
50%
Collected Data
50%
Primary Objective
50%
Characteristic Curve
50%
Pharmacology, Toxicology and Pharmaceutical Science
Major Depression
50%
Bipolar Disorder
50%
Combination Therapy
50%
Treatment Resistant Depression
50%
Risperidone
33%
Placebo
33%
Aripiprazole
33%
Ketamine
33%
Quetiapine
16%
Olanzapine
16%
Antidepressant
16%
Mirtazapine
16%
Randomized Controlled Trial
16%
Prevalence
16%
Depressive Disorder
8%
Remission
8%
Recurrent Disease
8%
